Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score

BACKGROUND: Gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) are heterogeneous in clinical course, biology, and outcomes. The NETPET score predicts survival by scoring uptake on dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT scans. We aimed to validate previous single-centre findings in a mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, David L., Hayes, Aimee R., Karfis, Ioannis, Conner, Alice, Furtado O’Mahony, Luke, Mileva, Magdalena, Bernard, Elizabeth, Roach, Paul, Marin, Gwennaëlle, Pavlakis, Nick, Schembri, Geoffrey, Gnanasegaran, Gopinath, Marin, Clementine, Vanderlinden, Bruno, Navalkissoor, Shaunak, Caplin, Martyn E., Flamen, Patrick, Toumpanakis, Christos, Bailey, Dale L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938218/
https://www.ncbi.nlm.nih.gov/pubmed/36434154
http://dx.doi.org/10.1038/s41416-022-02061-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938218/
https://www.ncbi.nlm.nih.gov/pubmed/36434154
http://dx.doi.org/10.1038/s41416-022-02061-5

Ejemplares similares